VEGFA and diabetes mellitus: In the analysis of the effects of peripheral blood mesenchymal stem cell transplantation on the angiogenic HIF-1/vascular endothelial growth factor (VEGF) pathway and miR-210 expression in diabetic foot rats, it was also found that peripheral blood mesenchymal stem cell transplantation may promote the proliferation and differentiation of endothelial cells and promote the formation of neovascularization by regulating the HIF-1/VEGF pathway and miR-210 expression [23,24,25].